[CIS PIDD] [cis-pidd] SubQ first dose

[Fabrício Prado Monteiro]

Same Marc!

                                   F!
www.imunoped.com.br







Il giorno 23/mag/2013, alle ore 16:50, "Riedl, Marc" <MRiedl at mednet.ucla.edu> ha scritto:


> IV: first dose always supervised in the infusion center.  SQ: comfortable

> with patients starting at home with nursing education/supervision.

> 

> Marc Riedl, M.D., M.S.

> Associate Professor of Medicine

> Section Head, Clinical Immunology and Allergy

> UCLA - David Geffen School of Medicine

> 10833 Le Conte Ave, 37-131 CHS

> Los Angeles, CA  90095-1680

> Tel 310.206.4345  Fax 310.267.0090

> 

> 

> 

> 

> 

> On 5/23/13 12:14 PM, "Sullivan, Kathleen" <sullivak at mail.med.upenn.edu>

> wrote:

> 

>> Question to allŠ

>> 

>> It has been our tradition to always give a first dose of any new

>> immunoglobulin product under medical supervision (i.e. not at home).   I

>> wonder how many people do that for subcutaneous products though.  I think

>> the risk of a reaction that needs medical attention is very low.

>> 

>> What do all of you do?

>> 

>> Kate

>> Kate Sullivan, MD PhD

>> Professor of Pediatrics

>> ARC 1216 Immunology CHOP

>> 3615 Civic Center Blvd.

>> Philadelphia, PA 19104

>> (p) 215-590-1697

>> (f) 267-426-0363

>> 

>> 

>> 

>> ---

>> The CIS-PIDD listserv is supported by the Clinical Immunology Society

>> The science & practice of human immunology

>> 

>> P: +1.414.224.8095

>> E: info at clinimmsoc.org

>> 

>> Not a member of CIS? Please visit www.clinimmsoc.org to join!

>> 

>> You are currently subscribed to cis-pidd as: mriedl at mednet.ucla.edu.

>> To unsubscribe click here:

>> http://lm.clinimmsoc.org/u?id=183824731.9896b573560aeeae864c3bfac00aa474&n

>> =T&l=cis-pidd&o=43387357

>> or send a blank email to

>> leave-43387357-183824731.9896b573560aeeae864c3bfac00aa474 at lists.clinimmsoc

>> .org

> 

> 

> 

> IMPORTANT WARNING:  This email (and any attachments) is only intended for the use of the person or entity to which it is addressed, and may contain information that is privileged and confidential.  You, the recipient, are obligated to maintain it in a safe, secure and confidential manner.  Unauthorized redisclosure or failure to maintain confidentiality may subject you to federal and state penalties. If you are not the intended recipient, please immediately notify us by return email, and delete this message from your computer.

> 

> ---

> The CIS-PIDD listserv is supported by the Clinical Immunology Society

> The science & practice of human immunology

> 

> P: +1.414.224.8095

> E: info at clinimmsoc.org

> 

> Not a member of CIS? Please visit www.clinimmsoc.org to join!

> 

> You are currently subscribed to cis-pidd as: fabriciopmonteiro at gmail.com.

> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824680.2ac404399b1fed9cf3ecfd2dfdce4844&n=T&l=cis-pidd&o=43390983

> or send a blank email to leave-43390983-183824680.2ac404399b1fed9cf3ecfd2dfdce4844 at lists.clinimmsoc.org


---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=43395748
or send a blank email to leave-43395748-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org